Pharma News
-
InnoPack China to provide pharma packaging solutions to APAC Region
Pharma | News | 0 Comment | 22 Nov, 2019
InnoPack China, a flagship exhibition of pharmaceutical packaging and drug delivery system with a considerable scale in Asia and the world, organized by Informa Markets and C...Read more
-
Teva increases offering and pricing size to $2.1 B
Pharma | News | 0 Comment | 21 Nov, 2019
Israeli company Teva Pharmaceutical Industries Limited (“Teva”) announced that it successfully upsized and priced approximately $2.1 billion (equivalent) of its senior notes (th...Read more
-
Excelra Collaborates with Maruho for Drug Repurposing
Pharma | News | 0 Comment | 20 Nov, 2019
Excelra, a leading global Data and Analytics Company on 20 Nov 2019 announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in ...Read more
-
Novo Nordisk explores liver cell targets with Dicerna
Pharma | News | 0 Comment | 20 Nov, 2019
US based Dicerna™ Pharmaceuticals, Inc. and Denmark headquartered Novo Nordisk A/S have announced an agreement to discover and develop novel therapies for the treatment of l...Read more
-
PSGL-1 immunotherapy to activate anti-tumor inflammatory response
Pharma | News | 0 Comment | 18 Nov, 2019
3SBio Inc. and Verseau Therapeutics, Inc. on 18 Nov 2019 announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under thei...Read more
-
Novartis to buy Aspen’s Japanese operations
Pharma | News | 0 Comment | 18 Nov, 2019
Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen...Read more
-
Pharma | News | 0 Comment | 18 Nov, 2019
Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) announced that it has entered into a definitive agreement for the sale...Read more
-
Clinical Trial of Boron Neutron Capture Therapy commences in Japan
Pharma | News | 0 Comment | 18 Nov, 2019
Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Boron Neutron Capture Therapy (BNCT) for malignant melanoma and angiosa...Read more
-
I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China
Pharma | News | 0 Comment | 15 Nov, 2019
I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated b...Read more
-
Takeda announces 12 new molecular entities
Pharma | News | 0 Comment | 15 Nov, 2019
Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to outline how its science-first, patient-centric strategy, diverse portfo...Read more
-
Mylan and Pfizer announce Viatris as new company name
Pharma | News | 0 Comment | 14 Nov, 2019
Mylan N.V. and Pfizer Inc. have announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pro...Read more
-
Novaliq, Jiangsu Hengrui focus on treatment of dry eye disease
Pharma | News | 0 Comment | 14 Nov, 2019
Novaliq GmbH, a Germany based pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co, Ltd., a fully integrated biopharmaceutical co...Read more
-
LEO Pharma, HitGen to develop novel class of derma drugs
Pharma | News | 0 Comment | 13 Nov, 2019
Denmark headquartered LEO Pharma A/S and China based HitGen Inc. are pleased to announce that HitGen and LEO Pharma expands their collaboration with a license to develop a novel class of dr...Read more
-
OSE Immunotherapeutics inks licensing deal with Chong Kun Dang Pharma
Pharma | News | 0 Comment | 12 Nov, 2019
French biotech company OSE Immunotherapeutics has announced a new licensing deal with South Korea based Chong Kun Dang (CKD) Pharmaceutical Corporation for Tedopi®, a combination o...Read more
-
FDA Grants De Novo Designation to Vela Diagnostics’ NGS HIV-1 Genotyping Assay
Pharma | News | 0 Comment | 11 Nov, 2019
Vela Diagnostics announced on 5 Nov 2019, that it has received FDA authorization to market its in vitro diagnostic test for the detection of HIV-1 genomic drug resistance mut...Read more
-
Novo Nordisk obtains worldwide licence to potential NASH candidate
Pharma | News | 0 Comment | 08 Nov, 2019
Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an exclusive worldwide licence to UBE’s preclinical asset UD-014, ...Read more
-
Takeda unveils new dengue vaccine manufacturing plant in Germany
Pharma | News | 0 Comment | 11 Nov, 2019
Japan based Takeda Pharmaceutical Company Limited has announced the opening of its new manufacturing plant in Singen, Germany, for its dengue vaccine candidate, TAK-003. The Singen vac...Read more
-
AstraZeneca announces three large-scale initiatives in China
Pharma | News | 0 Comment | 08 Nov, 2019
AstraZeneca has announced three large-scale initiatives to build on the Company’s long-standing commitment to China and advance global research and development (R&D) for innovativ...Read more
